Literature DB >> 19597271

A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis.

Khalid Anwar1, M P Barnes.   

Abstract

OBJECTIVE: To assess the validity and reliability of a Numeric Rating Scale (NRS) for the measurement of spasticity in multiple sclerosis.
DESIGN: Longitudinal study with multiple comparators over two clinic visits.
SETTING: Rehabilitation Centre in the North East of England, UK.
SUBJECTS: A total of thirty-five patients, with a diagnosis of multiple sclerosis (MS) that were attending a rehabilitation clinic.
RESULTS: The test/re-test reliability of the NRS showed there was a high correlation between the two visits (r = 0.672). Construct validity was assessed by examining the relationship between the mean spasticity NRS and each of the other spasticity assessment tools. There was a statistically significant correlation between subject's mean NRS diary scores and the Modified Ashworth Scale scores at both visits (Visit 1, r = 0.459, p = 0.0056; Visit 2, r = 0.446, p = 0.0106). There was a moderate, statistically significant correlation between the mean NRS diary scores and the Tardieu Scale (Visit 1, r = 0.429, p = 0.0113; Visit 2, r = 0.407, p = 0.0209).
CONCLUSIONS: The spasticity NRS has been shown to be a valid and reliable tool in the assessment of spasticity with a moderate to high level of correlation with other clinician rated instruments used to assess spasticity.

Entities:  

Mesh:

Year:  2009        PMID: 19597271     DOI: 10.3233/NRE-2009-0487

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  9 in total

1.  Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.

Authors:  Janice Cheung; Amanda Rancourt; Stephanie Di Poce; Amy Levine; Jessica Hoang; Farooq Ismail; Chris Boulias; Chetan P Phadke
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

2.  The 88-item Multiple Sclerosis Spasticity Scale: a Rasch validation of the Italian version and suggestions for refinement of the original scale.

Authors:  Leonardo Pellicciari; Marcella Ottonello; Andrea Giordano; Caterina Albensi; Franco Franchignoni
Journal:  Qual Life Res       Date:  2018-09-20       Impact factor: 4.147

3.  Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.

Authors:  Laura Ferrè; Arturo Nuara; Giulia Pavan; Marta Radaelli; Lucia Moiola; Mariaemma Rodegher; Bruno Colombo; Ignacio Juan Keller Sarmiento; Vittorio Martinelli; Letizia Leocani; Filippo Martinelli Boneschi; Giancarlo Comi; Federica Esposito
Journal:  Neurol Sci       Date:  2015-10-16       Impact factor: 3.307

Review 4.  Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.

Authors:  Uwe K Zettl; Paulus Rommer; Petra Hipp; Robert Patejdl
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

5.  Walking improvements with nabiximols in patients with multiple sclerosis.

Authors:  G Coghe; M Pau; F Corona; J Frau; L Lorefice; G Fenu; G Spinicci; E Mamusa; L Musu; S Massole; R Massa; M G Marrosu; E Cocco
Journal:  J Neurol       Date:  2015-08-05       Impact factor: 4.849

6.  A longitudinal study of self-reported spasticity among individuals with chronic spinal cord injury.

Authors:  Nicole D DiPiro; Chao Li; James S Krause
Journal:  Spinal Cord       Date:  2017-12-22       Impact factor: 2.772

7.  Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.

Authors:  Stephen Wright; Paul Duncombe; Douglas G Altman
Journal:  Trials       Date:  2012-10-09       Impact factor: 2.279

8.  Exploring physiotherapists' personality traits that may influence treatment outcome in patients with chronic diseases: a cohort study.

Authors:  Elisah Margretha Buining; Margit K Kooijman; Ilse C S Swinkels; Martijn F Pisters; Cindy Veenhof
Journal:  BMC Health Serv Res       Date:  2015-12-16       Impact factor: 2.655

9.  A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.

Authors:  Lucio Marinelli; Maurizio Balestrino; Laura Mori; Luca Puce; Gian Marco Rosa; Laura Giorello; Antonio Currà; Francesco Fattapposta; Carlo Serrati; Carlo Gandolfo; Giovanni Abbruzzese; Carlo Trompetto
Journal:  BMJ Open       Date:  2017-09-07       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.